This trial examines approaches to identify and care for individuals with inherited cancer syndrome. The purpose of this study is to offer no cost genetic testi…

BRCA1/2-Associated Hereditary Breast and Ovarian Cancer SyndromeBreast Ductal Carcinoma In SituHematopoietic and Lymphoid System Neoplasm+3 more

~Estimated

~$10 – $7,500

OHSU Knight Cancer InstituteNCT04494945

Effect of Polygenic Risk Modifiers on Decisions of BRCA1/2 Mutation Carriers at Risk for Prostate Cancer

The purpose of this study is to learn how people with BRCA1/2 mutations respond to genetic risk modifier testing. The researchers will learn more about how peo…

BRCA1/2Geneitic Testing

~Estimated

~$10 – $750

Memorial Sloan Kettering Cancer CenterNCT07197723

Responses to Genetic Risk Modifier Testing Among Women With Pathogenic Variants in Breast Cancer Predisposition Genes

The purpose of this study is to describe how women with BRCA1/2 mutations react to genetic risk modifier testing, and to examine how they make decisions about …

Genetic TestingBRCA1/2

~Estimated

~$10 – $750

Memorial Sloan Kettering Cancer CenterNCT03396341